Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €12.55 EUR
Change Today -0.14 / -1.10%
Volume 4.3K
CEREN On Other Exchanges
Symbol
Exchange
EN Paris
Frankfurt
As of 10:56 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

cerenis therapeutics holding (CEREN) Snapshot

Open
€12.70
Previous Close
€12.69
Day High
€12.70
Day Low
€12.49
52 Week High
05/15/15 - €13.35
52 Week Low
04/14/15 - €10.35
Market Cap
223.3M
Average Volume 10 Days
48.2K
EPS TTM
€-0.50
Shares Outstanding
17.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CERENIS THERAPEUTICS HOLDING (CEREN)

Related News

No related news articles were found.

cerenis therapeutics holding (CEREN) Related Businessweek News

No Related Businessweek News Found

cerenis therapeutics holding (CEREN) Details

Cerenis Therapeutics Holding SA, a biopharmaceutical company, discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases comprising non-alcoholic steatohepatitis. It is developing HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients; and HDL elevators for patients with low HDL. The company develops CER-001, an engineered complex of recombinant human apoA-I, the major structural protein of HDL, and phospholipids, which is in phase II clinical trials designed to mimic the structure and function of natural, nascent HDL, also known as pre-beta HDL. Cerenis Therapeutics Holding SA was founded in 2005 and is based in Labege, France.

9 Employees
Last Reported Date: 03/4/15
Founded in 2005

cerenis therapeutics holding (CEREN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cerenis therapeutics holding (CEREN) Key Developments

Cerenis Therapeutics Holding SA(ENXTPA:CEREN) added to CAC AllShares Index

Cerenis Therapeutics Holding SA has been added to CAC AllShares Index.

Cerenis Therapeutics Holding SA(ENXTPA:CEREN) added to Next Biotech Index

Cerenis Therapeutics Holding SA has been added to Next Biotech Index.

Cerenis Therapeutics Mulls IPO

Cerenis Therapeutics SA is mulling an IPO and has filed the paperwork in Europe.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEREN:FP €12.55 EUR -0.14

CEREN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CEREN.
View Industry Companies
 

Industry Analysis

CEREN

Industry Average

Valuation CEREN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERENIS THERAPEUTICS HOLDING, please visit www.cerenis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.